Key result
Transthoracic/subxiphoid ultrasound with the bubble test was found to be an easy, accurate, and safe method for verifying port usability in patients with persistent withdrawal occlusion.
Why the study?
Guidelines recommend infusing vesicant or antiblastic drugs through central venous ports only after assessing blood return, which is impossible in persistent withdrawal occlusion.
Does transthoracic/subxiphoid ultrasound with the 'bubble test' allow safe use of central venous ports in patients with persistent withdrawal occlusion?
Observational
Does transthoracic/subxiphoid ultrasound with the 'bubble test' allow safe use of central venous ports in patients with persistent withdrawal occlusion?
Answers are grounded in this paper and cite their sources.
Transthoracic/subxiphoid ultrasound with a bubble test offers a safe and accurate method to verify the usability of central venous ports in patients with persistent withdrawal occlusion, potentially avoiding unnecessary device removal or delays in chemotherapy.
Persistent withdrawal occlusion is a specific catheter malfunction characterized by inability to withdraw blood through the device while infusion is maintained. The main causes are fibroblastic sleeve and tip malposition (associated or not to venous thrombosis around the tip). All current guidelines recommend infusing vesicant/antiblastic drugs through a central venous port only after assessment of blood return. In PWO, blood return is impossible. We have recently started to assess the intravascular position of the tip and the delivery of the infusion in the proximity of the cavo-atrial junction utilizing transthoracic/subxiphoid ultrasound with the 'bubble test'. We found that this is an easy, real-time, accurate and safe method for verifying the possibility of using a port for chemotherapy even in the absence of blood return, as it occurs with persistent withdrawal occlusion.
No takes yet. Share an insight, caveat, or question.
D’Arrigo et al. (2021) conducted an observational in Persistent withdrawal occlusion in totally implantable venous access devices. Transthoracic/subxiphoid ultrasound with the bubble test was evaluated on Feasibility, accuracy, and safety of verifying port usability for chemotherapy. Transthoracic/subxiphoid ultrasound with the bubble test was found to be an easy, accurate, and safe method for verifying port usability in patients with persistent withdrawal occlusion.
Synapse has enriched 10 related papers. Consider them for comparative context: